The addition of antioxidant NAC to HCT116 cancer cells decreased the release of cytochrome c and Smac/DIABLO proteins, activation of caspase-3 and -7, and PARP cleavage, as well as phosphorylation of Bcl-2 proteins. The gene discussed is BCL2; the disease is cancer.